首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Bone marrow stromal cells-derived exosomes target DAB2IP to induce microglial cell autophagy a new strategy for neural stem cell transplantation in brain injury
【2h】

Bone marrow stromal cells-derived exosomes target DAB2IP to induce microglial cell autophagy a new strategy for neural stem cell transplantation in brain injury

机译:骨髓基质细胞 - 衍生的外泌体靶DAB2IP诱导小细胞细胞自噬是脑损伤中神经干细胞移植的新策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bone marrow stromal cells (MSCs) are a useful source of stem cells for the treatment of various brain injury diseases due to their abundant supply and fewer ethical problems compared with transplant treatment. However, the clinical application of MSCs is limited due to allograft rejection and immunosuppression in the process of MSCs transplantation. According to previous studies, microglial cell autophagy occurs following co-culture with MSCs. In the present study, exosomes were obtained from MSCs and subsequently characterized using transmission electron microscopy, atomic force microscopy and dynamic light scattering particle size analysis. The type of microRNAs (miRs) found in the exosomes was then analyzed via gene chip. The results demonstrated that microglial cell autophagy could be induced by exosomes. This mechanism was therefore investigated further via reverse transcription-quantitative PCR, western blotting and luciferase assays. These results demonstrated that exosomes from MSCs could induce microglial cell autophagy through the miR-32-mediated regulation of disabled homolog 2-interacting protein, thus providing a theoretical basis for the clinical application of miRs in MSCs.
机译:骨髓基质细胞(MSCs)是干细胞的有用源,用于治疗各种脑损伤疾病,由于其丰富的供应和较少的道德问题与移植治疗相比。然而,由于MSCs移植过程中的同种异体移植抑制和免疫抑制,MSCs的临床应用受到限制。根据先前的研究,通过MSC的共同培养后发生微胶质细胞自噬。在本研究中,从MSC获得外泌体,随后使用透射电子显微镜,原子力显微镜和动态光散射粒度分析表征。然后通过基因芯片分析外泌体中发现的微小RNA(miR)。结果表明,外胶质细胞自噬能量可以通过外泌体诱导。因此,通过逆转录定量PCR,Western印迹和荧光素酶测定进一步研究该机制。这些结果表明,来自MSCs的外虫剂可以通过MIR-32介导的残疾同源物2 - 相互作用蛋白的调节诱导微胶质细胞自噬,从而为MIR临床应用提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号